Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups

Yuichi Hirose, Kenneth Aldape, Andrew Bollen, C. David James, Daniel Brat, Kathleen Lamborn, Mitchel Berger, Burt G. Feuerstein

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Ependymoma occurs most frequently within the central nervous system of children and young adults. We determined relative chromosomal copy-number aberrations in 44 ependymomas using comparative genomic hybridization. The study included 24 intracranial and 20 spinal cord tumors from pediatric and adult patients. Frequent chromosomal aberrations in intracranial tumors were gain of 1q and losses on 6q, 9, and 13. Gain of 1q and loss on 9 were preferentially associated with histological grade 3 tumors. On the other hand, gain on chromosome 7 was recognized almost exclusively in spinal cord tumors, and was associated with various other chromosomal aberrations including frequent loss of 22q. We conclude that cytogenetic analysis of ependymomas may help to classify these tumors and provide leads concerning their initiation and progression. The relationship of these aberrations to patient outcome needs to be addressed.

Original languageEnglish
Pages (from-to)1137-1143
Number of pages7
JournalAmerican Journal of Pathology
Volume158
Issue number3
DOIs
Publication statusPublished - 01-01-2001
Externally publishedYes

Fingerprint

Ependymoma
Chromosome Aberrations
Spinal Cord Neoplasms
Neoplasms
Chromosomes, Human, Pair 7
Comparative Genomic Hybridization
Cytogenetic Analysis
Young Adult
Central Nervous System
Pediatrics

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Hirose, Y., Aldape, K., Bollen, A., James, C. D., Brat, D., Lamborn, K., ... Feuerstein, B. G. (2001). Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. American Journal of Pathology, 158(3), 1137-1143. https://doi.org/10.1016/S0002-9440(10)64061-8
Hirose, Yuichi ; Aldape, Kenneth ; Bollen, Andrew ; James, C. David ; Brat, Daniel ; Lamborn, Kathleen ; Berger, Mitchel ; Feuerstein, Burt G. / Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. In: American Journal of Pathology. 2001 ; Vol. 158, No. 3. pp. 1137-1143.
@article{f5fa1a3ffdd047038d88d72d2c69bc9d,
title = "Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups",
abstract = "Ependymoma occurs most frequently within the central nervous system of children and young adults. We determined relative chromosomal copy-number aberrations in 44 ependymomas using comparative genomic hybridization. The study included 24 intracranial and 20 spinal cord tumors from pediatric and adult patients. Frequent chromosomal aberrations in intracranial tumors were gain of 1q and losses on 6q, 9, and 13. Gain of 1q and loss on 9 were preferentially associated with histological grade 3 tumors. On the other hand, gain on chromosome 7 was recognized almost exclusively in spinal cord tumors, and was associated with various other chromosomal aberrations including frequent loss of 22q. We conclude that cytogenetic analysis of ependymomas may help to classify these tumors and provide leads concerning their initiation and progression. The relationship of these aberrations to patient outcome needs to be addressed.",
author = "Yuichi Hirose and Kenneth Aldape and Andrew Bollen and James, {C. David} and Daniel Brat and Kathleen Lamborn and Mitchel Berger and Feuerstein, {Burt G.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S0002-9440(10)64061-8",
language = "English",
volume = "158",
pages = "1137--1143",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "3",

}

Hirose, Y, Aldape, K, Bollen, A, James, CD, Brat, D, Lamborn, K, Berger, M & Feuerstein, BG 2001, 'Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups', American Journal of Pathology, vol. 158, no. 3, pp. 1137-1143. https://doi.org/10.1016/S0002-9440(10)64061-8

Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. / Hirose, Yuichi; Aldape, Kenneth; Bollen, Andrew; James, C. David; Brat, Daniel; Lamborn, Kathleen; Berger, Mitchel; Feuerstein, Burt G.

In: American Journal of Pathology, Vol. 158, No. 3, 01.01.2001, p. 1137-1143.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups

AU - Hirose, Yuichi

AU - Aldape, Kenneth

AU - Bollen, Andrew

AU - James, C. David

AU - Brat, Daniel

AU - Lamborn, Kathleen

AU - Berger, Mitchel

AU - Feuerstein, Burt G.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Ependymoma occurs most frequently within the central nervous system of children and young adults. We determined relative chromosomal copy-number aberrations in 44 ependymomas using comparative genomic hybridization. The study included 24 intracranial and 20 spinal cord tumors from pediatric and adult patients. Frequent chromosomal aberrations in intracranial tumors were gain of 1q and losses on 6q, 9, and 13. Gain of 1q and loss on 9 were preferentially associated with histological grade 3 tumors. On the other hand, gain on chromosome 7 was recognized almost exclusively in spinal cord tumors, and was associated with various other chromosomal aberrations including frequent loss of 22q. We conclude that cytogenetic analysis of ependymomas may help to classify these tumors and provide leads concerning their initiation and progression. The relationship of these aberrations to patient outcome needs to be addressed.

AB - Ependymoma occurs most frequently within the central nervous system of children and young adults. We determined relative chromosomal copy-number aberrations in 44 ependymomas using comparative genomic hybridization. The study included 24 intracranial and 20 spinal cord tumors from pediatric and adult patients. Frequent chromosomal aberrations in intracranial tumors were gain of 1q and losses on 6q, 9, and 13. Gain of 1q and loss on 9 were preferentially associated with histological grade 3 tumors. On the other hand, gain on chromosome 7 was recognized almost exclusively in spinal cord tumors, and was associated with various other chromosomal aberrations including frequent loss of 22q. We conclude that cytogenetic analysis of ependymomas may help to classify these tumors and provide leads concerning their initiation and progression. The relationship of these aberrations to patient outcome needs to be addressed.

UR - http://www.scopus.com/inward/record.url?scp=0035099106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035099106&partnerID=8YFLogxK

U2 - 10.1016/S0002-9440(10)64061-8

DO - 10.1016/S0002-9440(10)64061-8

M3 - Article

C2 - 11238062

AN - SCOPUS:0035099106

VL - 158

SP - 1137

EP - 1143

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 3

ER -